References
- Fassbender, K., Schmidt, R., Mossner, R., & others. (1998). Mood disorders and dysfunction of the hypothalamicpituitary-adrenal axis in multiple sclerosis: Association with cerebral inflammation. Archives of Neurology, 55, 66-72.
- Weiner, H. (2004). Curing MS: how science is solving the mysteries of multiple sclerosis. New York, NY: Crown Publishers.
- Lassmann, H., Bruck, W., & Lucchinetti, C.F. (2007). The immunopathology of multiple sclerosis: An overview. Brain Pathology, 17(2), 210-218.
- Breij, E.C., Brink, B.P., Veerhuis, R., & others. (2008). Homogeneity of active demyelinating lesions in established multiple sclerosis. Annals of Neurology, 63(1), 16-25.
- Hinson, S. R., Roemer, S. F., Lucchinetti, C. F., Mandler, R. N., Weigand, S. D., Lennon, V. A., McKeon, A. (2008). Aquaporin-4-binding autoantibodies in patients with neuromyelitis optica impair glutamate transport by downregulating EAAT2. The Journal of Experimental Medicine, 205(11), 2473–2481.
- Misu, T., Fujihara, K., Kakita, A., Nakamura, M., Watanabe, M., Nakashima, I., … Kira, J. (2007). Loss of aquaporin 4 in lesions of neuromyelitis optica: distinction from multiple sclerosis. Brain, 130(5), 1224–1234.
- Ramsaransing, G. S., & De Keyser, J. (2006). Benign course in multiple sclerosis: a review. Acta Neurologica Scandinavica, 113(6), 359–369.
- Pittock, S. J., McClelland, R. L., Mayr, W. T., Lucchinetti, C. F., & Wingerchuk, D. M. (2004). Clinical implications of benign multiple sclerosis: a 20-year population-based follow-up study. Annals of Neurology, 56(2), 303–306.
- Hawkins, S. A., & McDonnell, G. V. (1999). Benign multiple sclerosis? Clinical course, long term follow up, and assessment of prognostic factors. Journal of Neurology, Neurosurgery & Psychiatry, 67(2), 148–152.
- Authier, S., Berger, A. M., Liptak, Z., Duquette, P., & Antel, J. P. (2008). Benign MS is characterized by a lower rate of brain atrophy as compared to early MS. Archives of Neurology, 65(2), 209–214.
- Feinstein, A., O’Connor, P., Gray, T., & Feinstein, K. (1999). The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Multiple Sclerosis, 5(3), 323–326.
- Poeck, K. (1969). Pathophysiology of emotional disorders associated with brain damage. In P. J. Vinken & G. W. Bruyn (Eds.), Handbook of Clinical Neurology (Vol. 4, pp. 343–367). Amsterdam: North Holland Publishing.
- Feinstein, A., Feinstein, K., Gray, T., & O’Connor, P. (1997). Prevalence of neurobehavioral correlates of pathological laughing and crying in multiple sclerosis. Archives of Neurology, 54(11), 1116–1121.
- Seliger, G. M., Hornstein, A., Flax, J., Herbert, J., & Schroeder, K. (1992). Fluoxetine improved emotional incontinence. Brain Injury, 6, 267–270.
- Iannaccone, S., & Ferini-Strambi, L. (1996). Pharmacologic treatment of emotional lability. Clinical Neuropharmacology, 19, 532–535.
- Ruggieri, R. M., Palermo, R., Vitello, G., Gennuso, M., Settipani, N., & Piccoli, F. (2003). Cognitive impairment in patients suffering from relapsing-remitting multiple sclerosis with EDSS ≤ 3.5. Acta Neurologica Scandinavica, 108, 323–326.
- Al-Araji, A. H., & Orger, J. (2005). Reappraisal of Lhermitte's sign in multiple sclerosis. Multiple Sclerosis, 11(4), 398402.
- Thompson, A. (2005). Neurorehabilitation in multiple sclerosis: foundations, facts and fiction. Current Opinion in Neurology, 18, 267–271.
- Yorkston, K. M. (2005). Evidence for management of dysarthria and cognitive-communication problems in MS: development of practice guidelines in speech pathology. In Navigating the World of Multiple Sclerosis: Consortium of Multiple Sclerosis Centers Annual Meeting (pp. 1-5). June 1-5, 2005.
- Nazanin, N., Mohsen, K., Hossein, M., Alireza, D., Shamarina, S., Masoud, M., Rostam, J., Nader, S. (2020). The impact of physical exercises on the fatigue symptoms in patients with multiple sclerosis: a systematic review and meta-analysis. BMC Neurology, 20(1), 93.
- Perez de Heredia-Torres, M., Huertas-Hoyas, E., SanchezCamarero, C., Maximo-Bocanegra, N., Alegre-Ayala, J., Sanchez-Herrera-Baeza, P., Martinez-Piedrola, R., CarciaBravo, C., Mayoral-Martin, A., & Serrada-Tejeda, S. (2020). Occupational performance in multiple sclerosis and its relationship with quality of life and fatigue. European Journal of Physical and Rehabilitation Medicine, 56(2), 148154.
- Broch, L., Flemmen, H. O., Simonsen, C. S., Hansen, P. B., Ormstad, H., Brunborg, C., & Celius, E. G. (2022). Fatigue in multiple sclerosis is associated with socioeconomic factors. Multiple Sclerosis and Related Disorders, 64, 103955.